| Project/Area Number |
20591639
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Nippon Medical School |
|---|
Principal Investigator |
KUDO Mitsuhiro Nippon Medical School, 医学部, 講師 (20256978)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
ISHIWATA Toshiyuki 日本医科大学, 医学部, 准教授 (90203041)
NAITO Zenya 日本医科大学, 大学院・医学研究科, 教授 (20237184)
|
|---|
| Project Period (FY) |
2008 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2008: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 膵β細胞 / 3次元培養 / インスリン分泌 / 細胞接着 / 再生医療 / 幹細胞 |
|---|
| Research Abstract |
The differentiation of stem cells to pancreatic ss-cells, which produce and secrete insulin, is confirmed by several experimental studies, and the transplantation of such differentiated cells into patients with diabetes is actively studied. Such stem cell therapy will therefore require a large number of differentiated cells to obtain sufficient curative effects. We demonstrated that spheroid formation and suspension culture of ss-cells enhanced the insulin secretory capacity and sensitivity of ss-cells to sulfonylurea drugs such as tolbutamide via functional changes in insulin-secretion-related molecules.
|
